HWHG(SH:600079) Ge Long Hui·2025-11-28 10:17Core Viewpoint - The company, Renfu Pharmaceutical, is establishing a new investment fund focused on the health technology sector, collaborating with various investment partners to leverage their expertise and resources [1] Group 1: Investment Details - The newly formed fund, Wuhan Ruicheng New Drug Technology Achievement Transformation Venture Capital Fund Center (Limited Partnership), has an initial capital contribution of 250 million yuan [1] - The company will contribute 75 million yuan, representing 30% of the total initial capital commitment to the fund [1] - The fund primarily targets high-tech industries within the health sector [1] Group 2: Ownership and Related Transactions - The company holds a 32.25% equity stake in Wuhan Ruicheng, which is classified as an associated party under the Shanghai Stock Exchange listing rules [1] - The joint investment constitutes a related party transaction for the company [1]